231 related articles for article (PubMed ID: 12488299)
1. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours.
O'Sullivan JM; Huddart RA; Norman AR; Nicholls J; Dearnaley DP; Horwich A
Ann Oncol; 2003 Jan; 14(1):91-6. PubMed ID: 12488299
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors.
Thakkar DN; Ramasamy K; Adithan S; Selvarajan S; Dubashi B
J Cancer Res Ther; 2021; 17(2):443-449. PubMed ID: 34121690
[TBL] [Abstract][Full Text] [Related]
5. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-95: a review of patients with germ cell tumours.
Simpson AB; Paul J; Graham J; Kaye SB
Br J Cancer; 1998 Oct; 78(8):1061-6. PubMed ID: 9792151
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?
Donat SM; Levy DA
J Urol; 1998 Oct; 160(4):1347-52. PubMed ID: 9751352
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Martin WG; Ristow KM; Habermann TM; Colgan JP; Witzig TE; Ansell SM
J Clin Oncol; 2005 Oct; 23(30):7614-20. PubMed ID: 16186594
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced pneumonitis in three patients treated with chemotherapy for primary advanced seminoma.
Stein ME; Zidan J; Charas T; Gershuny A; Ben-Yosef R
J BUON; 2015; 20(3):928-32. PubMed ID: 26214649
[TBL] [Abstract][Full Text] [Related]
9. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
10. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
11. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Abou Yehia Z; Mikhaeel GN; Smith G; Pinnix CC; Milgrom SA; Tang C; Jiang W; Fanale MA; Oki Y; Shank JH; Horace T; Reddy J; Akhtari M; Gunther JR; Suki T; Allen PK; Turner S; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):951-958. PubMed ID: 27742539
[TBL] [Abstract][Full Text] [Related]
12. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
Kawai K; Hinotsu S; Tomobe M; Akaza H
Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
[TBL] [Abstract][Full Text] [Related]
13. Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients.
van der Schoot GGF; Westerink NL; Lubberts S; Nuver J; Zwart N; Walenkamp AME; Wempe JB; Meijer C; Gietema JA
Eur J Cancer; 2016 May; 59():134-141. PubMed ID: 27033261
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.
Kawai K; Akaza H
Expert Opin Drug Saf; 2003 Nov; 2(6):587-96. PubMed ID: 14585067
[TBL] [Abstract][Full Text] [Related]
16. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J
Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.
Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM
Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180
[TBL] [Abstract][Full Text] [Related]
19. Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
Sakamoto K; Ito S; Hashimoto N; Hasegawa Y
BMC Cancer; 2017 Aug; 17(1):526. PubMed ID: 28784103
[TBL] [Abstract][Full Text] [Related]
20. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]